Based on genomic profiles, prostate cancer can be divided into seven molecular subtypes which bear distinct oncogenic drivers including fusions with ETS family members (ERG, ETV1, ETV4, and FLI1) and mutations in SPOP, FOXA1, and IDH1 [29]. The gene discussed is ETV1; the disease is prostate carcinoma.